Which has preferable valuation and earnings, ITGR or BDSX?

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.54 Biodesix $88.50M 3.12 -$35.26M -$3.17 N/A

Is ITGR or BDSX more profitable?

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Integer 6.97% 12.79% 6.48% Biodesix -26.97% -788.19% -30.33%

Does the media prefer ITGR or BDSX?

In the previous week, Integer had 3 more articles in the media than Biodesix. MarketBeat recorded 7 mentions for Integer and 4 mentions for Biodesix. Integer's average media sentiment score of 0.79 beat Biodesix's score of 0.67 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Biodesix 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ELV or ITGR?

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $199.13B 0.44 $5.66B $22.50 18.09 Integer $1.85B 2.32 $102.81M $3.66 34.54

Does the media favor ELV or ITGR?

In the previous week, Elevance Health had 13 more articles in the media than Integer. MarketBeat recorded 20 mentions for Elevance Health and 7 mentions for Integer. Elevance Health's average media sentiment score of 1.45 beat Integer's score of 0.79 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 18 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BAX or ITGR?

In the previous week, Baxter International had 4 more articles in the media than Integer. MarketBeat recorded 11 mentions for Baxter International and 7 mentions for Integer. Baxter International's average media sentiment score of 1.33 beat Integer's score of 0.79 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 8 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Integer 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, PEN or ITGR?

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.40B 9.04 $177.69M $4.07 79.18 Integer $1.85B 2.32 $102.81M $3.66 34.54

Is PEN or ITGR more profitable?

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity. Company Net Margins Return on Equity Return on Assets Penumbra 10.67% 10.50% 8.17% Integer 6.97% 12.79% 6.48%

Does the media prefer PEN or ITGR?

In the previous week, Integer had 4 more articles in the media than Penumbra. MarketBeat recorded 7 mentions for Integer and 3 mentions for Penumbra. Penumbra's average media sentiment score of 1.54 beat Integer's score of 0.79 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Integer 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ITGR or SNN?

Smith & Nephew SNATS has higher revenue and earnings than Integer. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $3.66 34.54 Smith & Nephew SNATS $6.16B 1.97 $625M N/A N/A

Does the media refer more to ITGR or SNN?

In the previous week, Smith & Nephew SNATS had 5 more articles in the media than Integer. MarketBeat recorded 12 mentions for Smith & Nephew SNATS and 7 mentions for Integer. Integer's average media sentiment score of 0.79 beat Smith & Nephew SNATS's score of -0.14 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 3 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Integer (ITGR) Competitors

$126.40 -0.10 (-0.08%)

As of 09/4/2026 03:58 PM Eastern

Compare

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

Should you buy Integer stock or one of its competitors? Integer's main competitors and comparable companies include Biodesix (BDSX), Elevance Health (ELV), Baxter International (BAX), Penumbra (PEN), and Smith & Nephew SNATS (SNN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Integer compare to Biodesix?

Integer (NYSE:ITGR) and Biodesix (NASDAQ:BDSX) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.54
Biodesix	$88.50M	3.12	-$35.26M	-$3.17	N/A

Integer presently has a consensus target price of $109.86, indicating a potential downside of 13.09%. Biodesix has a consensus target price of $31.33, indicating a potential upside of 19.68%. Given Biodesix's stronger consensus rating and higher possible upside, analysts plainly believe Biodesix is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.80

Integer has a net margin of 6.97% compared to Biodesix's net margin of -26.97%. Integer's return on equity of 12.79% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Biodesix	-26.97%	-788.19%	-30.33%

99.3% of Integer shares are owned by institutional investors. Comparatively, 21.0% of Biodesix shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 23.2% of Biodesix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Integer had 3 more articles in the media than Biodesix. MarketBeat recorded 7 mentions for Integer and 4 mentions for Biodesix. Integer's average media sentiment score of 0.79 beat Biodesix's score of 0.67 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Biodesix	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Integer has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Biodesix has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Summary

Integer beats Biodesix on 11 of the 17 factors compared between the two stocks.

How does Integer compare to Elevance Health?

Elevance Health (NYSE:ELV) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Elevance Health has higher revenue and earnings than Integer. Elevance Health is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$199.13B	0.44	$5.66B	$22.50	18.09
Integer	$1.85B	2.32	$102.81M	$3.66	34.54

Elevance Health currently has a consensus price target of $440.90, indicating a potential upside of 8.32%. Integer has a consensus price target of $109.86, indicating a potential downside of 13.09%. Given Elevance Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Elevance Health is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	8 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.65
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Elevance Health has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 1.1% of Integer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Integer has a net margin of 6.97% compared to Elevance Health's net margin of 2.47%. Elevance Health's return on equity of 14.64% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.47%	14.64%	5.22%
Integer	6.97%	12.79%	6.48%

In the previous week, Elevance Health had 13 more articles in the media than Integer. MarketBeat recorded 20 mentions for Elevance Health and 7 mentions for Integer. Elevance Health's average media sentiment score of 1.45 beat Integer's score of 0.79 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	18 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Elevance Health beats Integer on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Baxter International?

Baxter International (NYSE:BAX) and Integer (NYSE:ITGR) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 1.1% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Integer has a net margin of 6.97% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Integer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
Integer	6.97%	12.79%	6.48%

Baxter International has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market.

In the previous week, Baxter International had 4 more articles in the media than Integer. MarketBeat recorded 11 mentions for Baxter International and 7 mentions for Integer. Baxter International's average media sentiment score of 1.33 beat Integer's score of 0.79 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	8 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integer	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Baxter International presently has a consensus target price of $22.45, indicating a potential downside of 13.00%. Integer has a consensus target price of $109.86, indicating a potential downside of 13.09%. Given Baxter International's higher probable upside, equities research analysts plainly believe Baxter International is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Integer has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.19	-$957M	-$2.07	N/A
Integer	$1.85B	2.32	$102.81M	$3.66	34.54

Summary

Integer beats Baxter International on 10 of the 16 factors compared between the two stocks.

How does Integer compare to Penumbra?

Penumbra (NYSE:PEN) and Integer (NYSE:ITGR) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

Penumbra has a net margin of 10.67% compared to Integer's net margin of 6.97%. Integer's return on equity of 12.79% beat Penumbra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.67%	10.50%	8.17%
Integer	6.97%	12.79%	6.48%

In the previous week, Integer had 4 more articles in the media than Penumbra. MarketBeat recorded 7 mentions for Integer and 3 mentions for Penumbra. Penumbra's average media sentiment score of 1.54 beat Integer's score of 0.79 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Integer	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Penumbra has higher earnings, but lower revenue than Integer. Integer is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	9.04	$177.69M	$4.07	79.18
Integer	$1.85B	2.32	$102.81M	$3.66	34.54

88.9% of Penumbra shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Penumbra presently has a consensus target price of $367.07, indicating a potential upside of 13.90%. Integer has a consensus target price of $109.86, indicating a potential downside of 13.09%. Given Penumbra's stronger consensus rating and higher probable upside, equities research analysts clearly believe Penumbra is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07

Penumbra has a beta of 0.7, indicating that its stock price is 30% less volatile than the broader market. Comparatively, Integer has a beta of 0.62, indicating that its stock price is 38% less volatile than the broader market.

Summary

Penumbra beats Integer on 12 of the 16 factors compared between the two stocks.

How does Integer compare to Smith & Nephew SNATS?

Integer (NYSE:ITGR) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

99.3% of Integer shares are owned by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Integer presently has a consensus price target of $109.86, indicating a potential downside of 13.09%. Smith & Nephew SNATS has a consensus price target of $30.93, indicating a potential upside of 6.97%. Given Smith & Nephew SNATS's higher probable upside, analysts clearly believe Smith & Nephew SNATS is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
Smith & Nephew SNATS	2 Sell rating(s)	8 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.91

In the previous week, Smith & Nephew SNATS had 5 more articles in the media than Integer. MarketBeat recorded 12 mentions for Smith & Nephew SNATS and 7 mentions for Integer. Integer's average media sentiment score of 0.79 beat Smith & Nephew SNATS's score of -0.14 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	3 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has a net margin of 6.97% compared to Smith & Nephew SNATS's net margin of 0.00%. Integer's return on equity of 12.79% beat Smith & Nephew SNATS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
Smith & Nephew SNATS	N/A	N/A	N/A

Integer has a beta of 0.62, suggesting that its stock price is 38% less volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

Smith & Nephew SNATS has higher revenue and earnings than Integer.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.54
Smith & Nephew SNATS	$6.16B	1.97	$625M	N/A	N/A

Summary

Integer beats Smith & Nephew SNATS on 9 of the 13 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITGR vs. The Competition

Export

Metric	Integer	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$4.30B	$5.66B	$7.21B	$23.59B
Dividend Yield	N/A	1.76%	2.54%	3.73%
P/E Ratio	34.54	25.99	273.82	29.33
Price / Sales	2.32	72.95	621.41	20.97
Price / Cash	12.20	33.42	28.92	19.95
Price / Book	2.54	6.10	11.01	4.83
Net Income	$102.81M	$150.94M	$3.49B	$1.07B
7 Day Performance	0.86%	-1.01%	1.65%	0.43%
1 Month Performance	1.07%	1.07%	4.44%	-0.78%
1 Year Performance	18.34%	9.96%	24.21%	12.82%

Integer Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITGR Integer	2.3894 of 5 stars	$126.40 -0.1%	$109.86 -13.1%	+18.3%	$4.30B	$1.85B	34.54	11,000
BDSX Biodesix	3.9722 of 5 stars	$25.78 -2.1%	$31.33 +21.5%	+196.6%	$271.98M	$88.50M	N/A	220
ELV Elevance Health	4.5967 of 5 stars	$400.29 +2.0%	$440.90 +10.1%	+29.7%	$86.81B	$199.13B	17.79	97,100	Positive News
BAX Baxter International	1.9018 of 5 stars	$26.28 +1.1%	$22.45 -14.6%	+5.7%	$13.59B	$11.24B	N/A	37,500	Positive News
PEN Penumbra	3.4522 of 5 stars	$322.71 -0.1%	$367.07 +13.7%	+14.5%	$12.71B	$1.40B	79.29	4,700	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ITGR) was last updated on 9/7/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

How does Integer compare to Biodesix?

Summary

How does Integer compare to Elevance Health?

Summary

How does Integer compare to Baxter International?

Summary

How does Integer compare to Penumbra?

Summary

How does Integer compare to Smith & Nephew SNATS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Integer (ITGR) Competitors

ITGR vs. BDSX, ELV, BAX, PEN, and SNN

How does Integer compare to Biodesix?

Which has preferable valuation and earnings, ITGR or BDSX?

Do analysts prefer ITGR or BDSX?

Is ITGR or BDSX more profitable?

Do institutionals and insiders have more ownership in ITGR or BDSX?

Does the media prefer ITGR or BDSX?

Which has more risk & volatility, ITGR or BDSX?

Summary

How does Integer compare to Elevance Health?

Which has higher earnings and valuation, ELV or ITGR?

Do analysts rate ELV or ITGR?

Which has more risk & volatility, ELV or ITGR?

Do institutionals & insiders hold more shares of ELV or ITGR?

Is ELV or ITGR more profitable?

Does the media favor ELV or ITGR?

Summary

How does Integer compare to Baxter International?

Do institutionals and insiders believe in BAX or ITGR?

Is BAX or ITGR more profitable?

Which has more volatility & risk, BAX or ITGR?

Does the media favor BAX or ITGR?

Do analysts rate BAX or ITGR?

Which has preferable valuation and earnings, BAX or ITGR?

Summary

How does Integer compare to Penumbra?

Is PEN or ITGR more profitable?

Does the media prefer PEN or ITGR?

Which has preferable earnings and valuation, PEN or ITGR?

Do institutionals & insiders believe in PEN or ITGR?

Do analysts recommend PEN or ITGR?

Which has more volatility and risk, PEN or ITGR?

Summary

How does Integer compare to Smith & Nephew SNATS?

Do institutionals and insiders believe in ITGR or SNN?

Do analysts recommend ITGR or SNN?

Does the media refer more to ITGR or SNN?

Is ITGR or SNN more profitable?

Which has more volatility & risk, ITGR or SNN?

Which has higher earnings and valuation, ITGR or SNN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITGR vs. The Competition

Integer Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools